Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Lentini

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
Investigational New Drugs|April 6, 2017
New doxorubicin nanocarriers based on cyclodextrinsMaurizio Viale, Valentina Giglio, Massimiliano Monticone, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|August 21, 2012
Three-year prospective study on fracture risk in postmenopausal women by quantitative ultrasound at the phalangesGiuseppe Guglielmi, Maurizio Rossini, Mario Guido Nicolosi, et al.
Ultrasonics Sonochemistry|July 19, 2020
Ultrasound and deep eutectic solvents: An efficient combination to tune the mechanism of steviol glycosides extractionGualtiero Milani, Maryline Vian, Maria Maddalena Cavalluzzi, et al.
International Journal of Molecular Sciences|March 29, 2023
A Comparative Study of the Inhibitory Action of Berberine Derivatives on the Recombinant Protein FtsZ of <i>E. coli</i>Angela Di Somma, Carolina Canè, Natalie Paola Rotondo, et al.
Pharmacology Research & Perspectives|October 31, 2015
Inhibition of hERG potassium channel by the antiarrhythmic agent mexiletine and its metabolite m-hydroxymexiletineRoberta Gualdani, Francesco Tadini-Buoninsegni, Mariagrazia Roselli, et al.
Drug Discovery Today|November 23, 2019
Human ether-à-go-go-related potassium channel: exploring SAR to improve drug designMaria Maddalena Cavalluzzi, Paola Imbrici, Roberta Gualdani, et al.
Molecules (Basel, Switzerland)|February 26, 2025
An Appealing, Robust Access to Furo-Fused HeteropolycyclesAlice Benzi, Lara Bianchi, Gianluca Giorgi, et al.
Chirality|March 8, 2006
Facile, alternative route to lubeluzole, its enantiomer, and the racemateClaudio Bruno, Alessia Carocci, Alessia Catalano, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 22, 2019
Novel lysophosphatidic acid receptor 6 antagonists inhibit hepatocellular carcinoma growth through affecting mitochondrial functionDavide Gnocchi, Saketh Kapoor, Patrizia Nitti, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|March 19, 2018
Molecular Insights into hERG Potassium Channel Blockade by LubeluzoleRoberta Gualdani, Maria Maddalena Cavalluzzi, Francesco Tadini-Buoninsegni, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
Investigational New Drugs|April 6, 2017
New doxorubicin nanocarriers based on cyclodextrinsMaurizio Viale, Valentina Giglio, Massimiliano Monticone, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|August 21, 2012
Three-year prospective study on fracture risk in postmenopausal women by quantitative ultrasound at the phalangesGiuseppe Guglielmi, Maurizio Rossini, Mario Guido Nicolosi, et al.
Ultrasonics Sonochemistry|July 19, 2020
Ultrasound and deep eutectic solvents: An efficient combination to tune the mechanism of steviol glycosides extractionGualtiero Milani, Maryline Vian, Maria Maddalena Cavalluzzi, et al.
International Journal of Molecular Sciences|March 29, 2023
A Comparative Study of the Inhibitory Action of Berberine Derivatives on the Recombinant Protein FtsZ of <i>E. coli</i>Angela Di Somma, Carolina Canè, Natalie Paola Rotondo, et al.
Pharmacology Research & Perspectives|October 31, 2015
Inhibition of hERG potassium channel by the antiarrhythmic agent mexiletine and its metabolite m-hydroxymexiletineRoberta Gualdani, Francesco Tadini-Buoninsegni, Mariagrazia Roselli, et al.
Drug Discovery Today|November 23, 2019
Human ether-à-go-go-related potassium channel: exploring SAR to improve drug designMaria Maddalena Cavalluzzi, Paola Imbrici, Roberta Gualdani, et al.
Molecules (Basel, Switzerland)|February 26, 2025
An Appealing, Robust Access to Furo-Fused HeteropolycyclesAlice Benzi, Lara Bianchi, Gianluca Giorgi, et al.
Chirality|March 8, 2006
Facile, alternative route to lubeluzole, its enantiomer, and the racemateClaudio Bruno, Alessia Carocci, Alessia Catalano, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 22, 2019
Novel lysophosphatidic acid receptor 6 antagonists inhibit hepatocellular carcinoma growth through affecting mitochondrial functionDavide Gnocchi, Saketh Kapoor, Patrizia Nitti, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|March 19, 2018
Molecular Insights into hERG Potassium Channel Blockade by LubeluzoleRoberta Gualdani, Maria Maddalena Cavalluzzi, Francesco Tadini-Buoninsegni, et al.
Pageof 11